マーケットレポート詳細
医薬品用容器包装の世界市場：タイプ別、原材料別2028年予測
Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2024年2月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文299ページになります。
- 商品コード：MAM3530
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
医薬品用容器包装の世界市場規模は2023年の1,320億ドルから、2028年に2,699億ドルへと急成長し、市場の平均年成長率は15.4%で推移することが見込まれています。
レポートは医薬品用容器包装の世界市場について2028年までの市場予測データ(金額US$、量ベースKiloton)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（パッケージタイプ別市場、原材料別市場、等）を中心に構成されています。また競合状況、主要企業情報（11社）、市場ダイナミクス、バリューチェーン分析などの分析も加味し、医薬品用容器包装市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆医薬品用容器包装の世界市場予測2020-2028年
・市場規模(US$)
・量ベース(Kiloton)
◆パッケージタイプ別、市場-2028年
・プライマリ
・セカンダリ
※(市場規模US$)
◆原材料別、市場-2028年
・プラスチック
・紙、板紙
・ガラス
・金属
・その他原材料
※(市場規模US$、量ベースKiloton)
◆薬物送達別、市場-2028年
・経口
・経肺
・経皮
・注射剤
・局所
・経鼻
・眼内/眼科的
・静脈
・その他薬物送達
※(市場規模US$)
◆タイプ別、市場-2028年
・プラスチックボトル
・ブリスターパック
・ラベル/アクセサリ
・キャップ/クロージャ
・医療用特殊バック
・プレフィルドシリンジ
・温度調節包装
・ポーチ/ストリップパック
・アンプル
・バイアル
・薬剤充填済み吸入器
・医療用チューブ
・瓶/キャニスタ
・カートリッジ
・その他タイプ
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ、メキシコ
欧州
・ドイツ、フランス、イタリア
・英国、スペイン、ロシア
・その他欧州
アジア太平洋
・日本、中国、韓国、インド、オーストラリア
・その他アジア太平洋
南米
・ブラジル、アルゼンチン
・その他南米
中東アフリカ
・GCC諸国（UAE、サウジアラビア、その他GCC諸国）、南アフリカ
・その他中東アフリカ
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※国別にタイプ別の細分化データ掲載
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・バリューチェーン分析
・業界構造分析（ファイブフォース分析）
・マクロ経済指標
・関税と規制の状況
・価格分析
・エコシステム/市場マップ
・特許分析
・貿易分析
・主要なステークホルダーと購買基準
・競合状況
・市場シェア分析
◆医薬品用容器包装の主要企業プロフィール動向
・BERRY GLOBAL INC.
・GERRESHEIMER AG
・AMCOR PLC
・SCHOTT AG
・APTARGROUP, INC.
・BD
・WESTROCK COMPANY
・ニプロ株式会社
・CATALENT, INC.
・SEALED AIR
・WEST PHARMACEUTICAL SERVICES, INC.
（その他企業）
・ALPLA
・ARDAGH GROUP S.A.
・CCL INDUSTRIES INC.
・FRANK NOE
・GAPLAST GMBH
・LONZA
・MONDI GROUP
・NOLATO AB
・ORIGIN PHARMA PACKAGING
・COMAR
・BILCARE LIMITED
・SGD PHARMA
・SILGAN HOLDINGS INC.
・VETTER PHARMA INTERNATIONAL GMBH
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
・ TABLE 1 PHARMACEUTICAL PACKAGING MARKET: INCLUSIONS & EXCLUSIONS
1.4 STUDY SCOPE 41
・ FIGURE 1 PHARMACEUTICAL PACKAGING MARKET SEGMENTATION
1.4.1 REGIONS COVERED 42
・ FIGURE 2 REGIONAL SCOPE
1.4.2 YEARS CONSIDERED 42
1.5 CURRENCY CONSIDERED
1.6 UNITS CONSIDERED
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 3 PHARMACEUTICAL PACKAGING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 KEY SECONDARY SOURCES
2.1.1.2 KEY DATA FROM SECONDARY SOURCES
2.1.2 PRIMARY DATA
2.1.2.1 KEY PRIMARY SOURCES
2.1.2.2 KEY DATA FROM PRIMARY SOURCES
2.1.2.3 KEY INDUSTRY INSIGHTS
2.1.2.4 BREAKDOWN OF PRIMARY INTERVIEWS
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
・ FIGURE 4 PHARMACEUTICAL PACKAGING MARKET: BOTTOM-UP APPROACH
2.2.2 TOP-DOWN APPROACH 49
・ FIGURE 5 PHARMACEUTICAL PACKAGING MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
・ FIGURE 6 PHARMACEUTICAL PACKAGING MARKET: DATA TRIANGULATION
2.3.1 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH PRIMARY SOURCES
2.3.2 PHARMACEUTICAL PACKAGING MARKET ANALYSIS THROUGH SECONDARY SOURCES
・ FIGURE 7 PHARMACEUTICAL PACKAGING MARKET ANALYSIS
2.4 RESEARCH ASSUMPTIONS
2.5 FACTOR ANALYSIS
2.6 GROWTH ESTIMATION
2.6.1 SUPPLY SIDE
2.6.2 DEMAND SIDE
2.7 LIMITATIONS & RISKS
2.8 RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 8 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
・ FIGURE 9 PLASTICS TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD
・ FIGURE 10 ORAL DRUG DELIVERY MODE TO DOMINATE MARKET DURING FORECAST PERIOD
・ FIGURE 11 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
・ FIGURE 12 ASIA PACIFIC TO BE FASTEST-GROWING PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD
4 PREMIUM INSIGHTS
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PHARMACEUTICAL PACKAGING MARKET
・ FIGURE 13 ASIA PACIFIC TO OFFER LUCRATIVE OPPORTUNITIES IN PHARMACEUTICAL PACKAGING MARKET DURING FORECAST PERIOD 60
4.2 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
・ FIGURE 14 PREFILLED SYRINGES TO RECORD FASTEST GROWTH DURING
FORECAST PERIOD
4.3 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
・ FIGURE 15 PLASTICS SEGMENT TO RECORD HIGHEST CAGR DURING FORECAST PERIOD
4.4 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
・ FIGURE 16 INJECTABLES SEGMENT TO BE FASTEST-GROWING MARKET BY 2028
4.5 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
・ FIGURE 17 PRIMARY SEGMENT TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
4.6 PHARMACEUTICAL PACKAGING MARKET, BY KEY COUNTRY
・ FIGURE 18 INDIA TO DOMINATE MARKET DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 19 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PHARMACEUTICAL PACKAGING MARKET
5.2.1 DRIVERS
5.2.1.1 SURGE IN HEALTHCARE EXPENDITURE AND GROWTH OF PHARMACEUTICAL INDUSTRY
5.2.1.2 RISING DEMAND FOR DRUG DELIVERY DEVICES AND BLISTER PACKAGING 66
5.2.1.3 TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL PACKAGING
5.2.1.3.1 NANOMEDICINE AND NANO DRUG DELIVERY SYSTEMS
5.2.1.3.2 CHILD-RESISTANT PACKAGING
5.2.1.3.3 RADIO-FREQUENCY IDENTIFICATION
5.2.1.3.4 MICRO-PUMP TECHNOLOGY
5.2.1.3.5 ECO-FRIENDLY AND SUSTAINABLE PACKAGING
5.2.2 RESTRAINTS
5.2.2.1 SURGE IN PACKAGING COSTS DUE TO DYNAMIC REGULATORY POLICIES
5.2.2.2 RESTRICTED ACCESS TO HEALTHCARE SYSTEMS IN EMERGING ECONOMIES
5.2.3 OPPORTUNITIES
5.2.3.1 GROWING DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING
5.2.4 CHALLENGES
5.2.4.1 SAFEGUARDING AGAINST COUNTERFEIT PRODUCTS
5.3 VALUE CHAIN ANALYSIS
・ FIGURE 20 PHARMACEUTICAL PACKAGING MARKET: VALUE CHAIN ANALYSIS
5.3.1 RAW MATERIAL SUPPLIERS
5.3.2 R&D OF PRODUCTS
5.3.3 MANUFACTURERS
5.3.4 DISTRIBUTORS
5.3.5 END USERS
5.4 PORTER’S FIVE FORCES ANALYSIS
・ FIGURE 21 PORTER’S FIVE FORCES ANALYSIS OF PHARMACEUTICAL PACKAGING MARKET
5.4.1 THREAT OF NEW ENTRANTS
5.4.2 THREAT OF SUBSTITUTES
5.4.3 BARGAINING POWER OF BUYERS
5.4.4 BARGAINING POWER OF SUPPLIERS
5.4.5 INTENSITY OF COMPETITIVE RIVALRY
・ TABLE 2 IMPACT OF PORTER’S FIVE FORCES ON PHARMACEUTICAL PACKAGING MARKET
5.5 MACROECONOMIC INDICATORS
5.5.1 GLOBAL GDP TRENDS 75
・ TABLE 3 TRENDS OF PER CAPITA GDP (USD), 2019–2021
・ TABLE 4 GDP GROWTH ESTIMATE AND PROJECTION OF KEY COUNTRIES, 2022–2027
・ TABLE 5 CURRENT HEALTH EXPENDITURE (% OF GDP) OF KEY COUNTRIES, 2018–2020
5.6 TARIFF & REGULATORY LANDSCAPE
5.6.1 REGULATIONS
5.6.1.1 EUROPE
5.6.1.2 US
5.6.1.3 OTHERS
5.6.2 STANDARDS
5.6.2.1 ISO 9001
5.6.2.2 ISO 22000
5.6.2.3 ASTM D3475
5.6.2.4 USP (UNITED STATES PHARMACOPEIA) STANDARDS
5.6.2.5 CHILD-RESISTANT PACKAGING STANDARDS
5.6.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
・ TABLE 6 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.7 TECHNOLOGY ANALYSIS
5.7.1 NANOTECHNOLOGY
5.7.2 PACKAGING FOR BIOLOGICS
5.7.3 SMART PACKAGING 81
5.7.4 ANTI-COUNTERFEIT PACKAGING
5.7.5 OTHER SMART TRENDS AND TECHNOLOGIES
5.8 PRICING ANALYSIS
5.8.1 AVERAGE SELLING PRICE, BY REGION
・ FIGURE 22 AVERAGE SELLING PRICE, BY REGION (USD/KG)
5.8.2 AVERAGE SELLING PRICE, BY RAW MATERIAL
・ TABLE 7 AVERAGE SELLING PRICE, BY RAW MATERIAL (USD/KG)
5.9 ECOSYSTEM/MARKET MAP
・ FIGURE 23 PHARMACEUTICAL PACKAGING MARKET: ECOSYSTEM MAPPING
・ TABLE 8 PHARMACEUTICAL PACKAGING MARKET: ROLE IN ECOSYSTEM
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
・ FIGURE 24 SUSTAINABLE PACKAGING, IOT, AND NANOTECHNOLOGY TO DRIVE FUTURE GROWTH
5.11 PATENT ANALYSIS
5.11.1 INTRODUCTION
5.11.2 METHODOLOGY
5.11.3 DOCUMENT TYPES
・ FIGURE 25 PATENTS REGISTERED (2012–2022)
5.11.4 PUBLICATION TRENDS
・ FIGURE 26 NUMBER OF PATENTS IN LAST 10 YEARS, 2012–2022
5.11.5 INSIGHTS
5.11.6 JURISDICTION ANALYSIS
・ FIGURE 27 TOP JURISDICTIONS
5.11.7 TOP APPLICANTS
・ FIGURE 28 TOP 10 PATENT APPLICANTS
・ TABLE 9 PATENTS BY SANOFI
・ TABLE 10 PATENTS BY SCHOTT AG
・ TABLE 11 PATENTS BY NOVARTIS AG
・ FIGURE 29 TOP 10 PATENT OWNERS
・ TABLE 12 TOP 10 PATENT OWNERS IN LAST 10 YEARS
5.12 RAW MATERIAL ANALYSIS
5.12.1 PLASTICS
5.12.2 PAPER
5.12.3 GLASS
5.12.4 METALS
5.13 TRADE ANALYSIS
5.13.1 IMPORT SCENARIO 92
・ TABLE 13 REGION-WISE IMPORT TRADE (USD MILLION)
・ FIGURE 30 REGION-WISE IMPORT TRADE (USD MILLION)
5.13.2 EXPORT SCENARIO 93
・ TABLE 14 REGION-WISE EXPORT TRADE (USD MILLION)
・ FIGURE 31 REGION-WISE EXPORT TRADE (USD MILLION)
5.14 KEY CONFERENCES & EVENTS IN 2024–2025
・ TABLE 15 KEY CONFERENCES & EVENTS IN 2023–2024
5.15 CASE STUDY ANALYSIS
5.15.1 MOISTURE BARRIER TECHNOLOGY FOR EFFICIENT DRUG DELIVERY
5.15.2 CUSTOM METERING VALVE FOR INHALERS
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
・ TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE DRUG DELIVERY MODES
5.16.2 BUYING CRITERIA
5.16.2.1 QUALITY
5.16.2.2 SERVICE
・ FIGURE 32 SUPPLIER SELECTION CRITERION 96
6 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE
6.1 INTRODUCTION
・ FIGURE 33 PRIMARY PACKAGING TO ACCOUNT FOR LARGER SHARE DURING FORECAST PERIOD
・ TABLE 17 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 18 PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
6.2 PRIMARY
6.2.1 INNOVATIVE PACKAGING SOLUTIONS FOR DRUG DELIVERY SYSTEMS TO DRIVE MARKET
6.3 SECONDARY 100
6.3.1 RISING ADOPTION OF PREFILLED CONTAINERS AND DELIVERY DEVICES TO FUEL DEMAND
7 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL
7.1 INTRODUCTION
・ FIGURE 34 PLASTICS TO DOMINATE MARKET DURING FORECAST PERIOD
・ TABLE 19 BASIC PACKAGING RAW MATERIALS USED IN PHARMACEUTICAL PACKAGING
・ TABLE 20 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 21 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
・ TABLE 22 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 23 PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
7.2 PLASTIC
7.2.1 EFFECTIVE BARRIER PROPERTIES AND COST REDUCTION TO DRIVE MARKET
・ TABLE 24 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 25 PLASTICS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.2.2 HIGH-DENSITY POLYETHYLENE
7.2.3 POLYESTER
7.2.4 POLYPROPYLENE
7.2.5 LOW-DENSITY POLYETHYLENE
7.2.6 POLYVINYL CHLORIDE
7.2.7 CYCLIC OLEFIN COPOLYMER
7.2.8 POLYETHYLENE TEREPHTHALATE
7.3 PAPER & PAPERBOARD
7.3.1 INNOVATIONS IN SECONDARY PACKAGING TO PROPEL MARKET
・ TABLE 26 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 27 PAPER & PAPERBOARD: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.4 GLASS
7.4.1 CHEMICAL RESISTANCE AND STURDINESS TO BOOST DEMAND
・ TABLE 28 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 29 GLASS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
・ TABLE 30 GLASS PACKAGING TYPES
7.5 METALS
7.5.1 INCREASING USE OF ALUMINUM FOR BLISTER PACKAGING TO DRIVE MARKET
・ TABLE 31 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 32 METALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
7.6 OTHER RAW MATERIALS
・ TABLE 33 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 34 OTHER RAW MATERIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY
8.1 INTRODUCTION
・ FIGURE 35 ORAL DRUG DELIVERY ACCOUNTED FOR LARGEST SHARE IN 2023
・ TABLE 35 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 36 DRUG DELIVERY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
・ TABLE 37 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 38 PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
8.2 ORAL
8.2.1 ADOPTION OF NANOCARRIERS AND CYCLODEXTRINS TO FUEL MARKET
・ TABLE 39 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 40 ORAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.3 PULMONARY 117
8.3.1 INCREASING CASES OF LUNG DISORDERS TO DRIVE MARKET
・ TABLE 41 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 42 PULMONARY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.4 TRANSDERMAL 118
8.4.1 SURGING DEMAND FOR PAINLESS DRUG DELIVERY AND SELF-ADMINISTRATION OF DRUGS TO FUEL MARKET 118
・ TABLE 43 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 44 TRANSDERMAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.5 INJEC・ TABLE
8.5.1 INCREASING USE OF BIOLOGICS TO BOOST MARKET
・ TABLE 45 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 46 INJECTABLE: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.6 TOPICAL
8.6.1 RISING PREVALENCE OF SKIN DISEASES TO BOOST DEMAND FOR TOPICAL DRUGS
・ TABLE 47 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 48 TOPICAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.7 NASAL
8.7.1 RAPID ABSORPTION AND QUICK ACTION TO FUEL DEMAND FOR NASAL DROPS
・ TABLE 49 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 50 NASAL: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.8 OCULAR/OPHTHALMIC
8.8.1 INCREASING FREQUENCY OF OPTHALMIC DISEASES TO DRIVE MARKET
・ TABLE 51 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 52 OCULAR/OPHTHALMIC: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.9 INTRAVENOUS 123
8.9.1 HIGH OCCURENCE OF CHRONIC DISEASES TO FUEL MARKET
・ TABLE 53 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 54 INTRAVENOUS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
8.10 OTHER DRUG DELIVERY MODES
・ TABLE 55 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 56 OTHER DRUG DELIVERY MODES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9 PHARMACEUTICAL PACKAGING MARKET, BY TYPE
9.1 INTRODUCTION
・ FIGURE 36 PLASTIC BOTTLES TO ACCOUNT FOR LARGEST SHARE DURING FORECAST PERIOD
・ TABLE 57 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 58 PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
9.2 PLASTIC BOTTLES
9.2.1 EXTENSIVE USE IN PACKAGING ORAL DRUGS TO BOOST MARKET
・ TABLE 59 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 60 PLASTIC BOTTLES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.2.2 STANDARD PLASTIC BOTTLES
9.2.3 PLASTIC DISPENSING BOTTLES
9.2.4 PLASTIC JARS
9.3 BLISTER PACKS
9.3.1 ANTIMICROBIAL RESISTANCE AND TAMPER-EVIDENT FEATURES TO DRIVE MARKET
・ TABLE 61 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 62 BLISTER PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.3.2 COMPARTMENT PACKS 131
9.3.3 WALLET PACKS
9.4 LABELS & ACCESSORIES
9.4.1 NEED FOR STRINGENT GUIDELINES ON DRUG INSTRUCTIONS TO FUEL DEMAND
・ TABLE 63 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 64 LABELS & ACCESSORIES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.4.2 SELF ADHESIVE
9.4.3 DIE CUT
9.4.4 HOLOGRAPHIC STRIPS
9.4.5 TAMPER PROOF
9.4.6 OTHER LABELS
9.5 CAPS & CLOSURES
9.5.1 DEMAND FOR CHILD-RESISTANT AND TAMPER-EVIDENT PACKAGING TO FUEL MARKET
・ TABLE 65 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 66 CAPS & CLOSURES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.6 MEDICAL SPECIALTY BAGS
9.6.1 INCREASING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND
・ TABLE 67 MEDICAL SPECIALTY BAGS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 68 MEDICAL SPECIALTY: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.7 PREFILLED SYRINGES
9.7.1 RISING NEED FOR HIGH-QUALITY DRUG DELIVERY SYSTEMS TO BOOST MARKET
・ TABLE 69 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 70 PREFILLED SYRINGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.8 TEMPERATURE-CONTROLLED PACKAGING
9.8.1 SURGING DEMAND FOR TEMPERATURE-SENSITIVE DRUGS AND VACCINES TO FUEL MARKET
・ TABLE 71 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 72 TEMPERATURE-CONTROLLED PACKAGING: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.9 POUCHES & STRIP PACKS
9.9.1 INCREASING DEMAND FOR COST-EFFECTIVE SOLUTIONS TO DRIVE MARKET
・ TABLE 73 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 74 POUCHES & STRIP PACKS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.10 AMPOULES
9.10.1 HIGH REQUIREMENT FOR SMALL DOSAGE SOLUTIONS TO DRIVE MARKET
・ TABLE 75 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 76 AMPOULES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.11 VIALS
9.11.1 CONSISTENT DEMAND FOR VIALS IN VACCINE PACKAGING TO DRIVE MARKET
・ TABLE 77 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 78 VIALS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12 PREFILLED INHALERS
9.12.1 HIGH DEMAND FOR CONVENIENT AND ECO-FRIENDLY PACKAGING TO DRIVE MARKET
・ TABLE 79 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 80 PREFILLED INHALERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.12.2 METERED DOSE INHALERS
9.12.3 DRY POWDER INHALERS
9.13 MEDICATION TUBES
9.13.1 INCREASING DEMAND IN CURING SKIN AILMENTS TO DRIVE MARKET
・ TABLE 81 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 82 MEDICATION TUBES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.13.2 COMPOSITE TUBES 144
9.13.3 ALL-PLASTIC TUBES 144
9.13.4 COLLAPSIBLE METAL TUBES
9.14 JARS & CANISTERS
9.14.1 EFFECTIVE BARRIER PROPERTIES TO FUEL DEMAND FOR DESICCANT CANISTERS
・ TABLE 83 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 84 JARS & CANISTERS: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.15 CARTRIDGES 146
9.15.1 INCREASED USE IN CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 85 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 86 CARTRIDGES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
9.16 OTHER TYPES 147
・ TABLE 87 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 88 OTHER TYPES: PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10 PHARMACEUTICAL PACKAGING MARKET, BY REGION
10.1 INTRODUCTION
・ FIGURE 37 INDIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
・ TABLE 89 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2020–2022 (USD MILLION)
・ TABLE 90 PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2023–2028 (USD MILLION)
10.2 NORTH AMERICA
10.2.1 RECESSION IMPACT 150
・ FIGURE 38 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
・ TABLE 91 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
・ TABLE 92 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
・ TABLE 93 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 94 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
・ TABLE 95 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 96 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
・ TABLE 97 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 98 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
・ TABLE 99 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 100 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
・ TABLE 101 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 102 NORTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.2.2 US
10.2.2.1 RAPID TECHNOLOGICAL ADVANCEMENTS IN PHARMACEUTICAL PACKAGING TO DRIVE MARKET
・ TABLE 103 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 104 US: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.3 CANADA
10.2.3.1 COMPETITIVE BUSINESS ENVIRONMENT TO BOOST MARKET
・ TABLE 105 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 106 CANADA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.2.4 MEXICO
10.2.4.1 GOVERNMENT INITIATIVES IN HEALTHCARE INDUSTRY TO FUEL DEMAND FOR PHARMACEUTICAL PRODUCTS
・ TABLE 107 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 108 MEXICO: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3 EUROPE
10.3.1 RECESSION IMPACT 163
・ FIGURE 39 EUROPE: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
・ TABLE 109 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
・ TABLE 110 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
・ TABLE 111 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 112 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
・ TABLE 113 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 114 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
・ TABLE 115 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 116 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
・ TABLE 117 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 118 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
・ TABLE 119 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 120 EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.3.2 GERMANY
10.3.2.1 INCREASE IN AGING POPULATION AND NONCOMMUNICABLE DISEASES TO DRIVE MARKET
・ TABLE 121 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 122 GERMANY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 HIGH DEMAND FOR GENERIC DRUGS TO DRIVE MARKET
・ TABLE 123 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 124 FRANCE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 RISING EXPORTS OF PHARMACEUTICAL PRODUCTS TO BOOST MARKET
・ TABLE 125 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 126 ITALY: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.5 UK
10.3.5.1 INNOVATIONS IN DRUG MANUFACTURING TO DRIVE MARKET
・ TABLE 127 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 128 UK: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 GOVERNMENT INITIATIVES IN HEALTHCARE SECTOR TO BOOST DEMAND
・ TABLE 129 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 130 SPAIN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.7 RUSSIA
10.3.7.1 GOVERNMENT INITIATIVES FOR DOMESTIC PRODUCTION OF PHARMACEUTICALS TO FUEL MARKET
・ TABLE 131 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 132 RUSSIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.3.8 REST OF EUROPE
・ TABLE 133 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 134 REST OF EUROPE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4 ASIA PACIFIC
10.4.1 RECESSION IMPACT 182
・ FIGURE 40 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET SNAPSHOT
・ TABLE 135 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
・ TABLE 136 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
・ TABLE 137 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 138 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
・ TABLE 139 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 140 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
・ TABLE 141 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 142 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
・ TABLE 143 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 144 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
・ TABLE 145 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 146 ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.4.2 CHINA
10.4.2.1 INCREASED INVESTMENTS IN BIOLOGICS AND BIOSIMILAR DRUG RESEARCH TO DRIVE MARKET
・ TABLE 147 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 148 CHINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.3 JAPAN
10.4.3.1 RISE IN AGING POPULATION TO DRIVE DEMAND FOR MEDICATIONS
・ TABLE 149 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 150 JAPAN: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.4 SOUTH KOREA
10.4.4.1 WELL-DEVELOPED HEALTHCARE INDUSTRY AND PRESENCE OF MAJOR PHARMACEUTICALS MANUFACTURERS TO DRIVE MARKET
・ TABLE 151 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 152 SOUTH KOREA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.5 INDIA
10.4.5.1 LARGE DOMESTIC CONSUMPTION AND EXPORT OF GENERIC DRUGS TO DRIVE MARKET 194
・ TABLE 153 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 154 INDIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.6 AUSTRALIA
10.4.6.1 WIDE ADOPTION OF MEDICARE AND PBS SCHEMES TO DRIVE MARKET
・ TABLE 155 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 156 AUSTRALIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
・ TABLE 157 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 158 REST OF ASIA PACIFIC: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5 SOUTH AMERICA
10.5.1 RECESSION IMPACT 199
・ TABLE 159 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
・ TABLE 160 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
・ TABLE 161 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 162 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
・ TABLE 163 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 164 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
・ TABLE 165 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 166 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
・ TABLE 167 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 168 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
・ TABLE 169 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 170 SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.5.2 BRAZIL
10.5.2.1 FREE AND UNIVERSAL HEALTHCARE SERVICES TO BOOST MARKET
・ TABLE 171 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 172 BRAZIL: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.3 ARGENTINA
10.5.3.1 RAPID URBANIZATION AND INCREASE IN IMPORT OF DRUGS TO FUEL MARKET
・ TABLE 173 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 174 ARGENTINA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.5.4 REST OF SOUTH AMERICA
・ TABLE 175 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 176 REST OF SOUTH AMERICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 RECESSION IMPACT 209
・ TABLE 177 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2020–2022 (USD MILLION)
・ TABLE 178 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY COUNTRY, 2023–2028 (USD MILLION)
・ TABLE 179 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 180 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
・ TABLE 181 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2020–2022 (USD MILLION)
・ TABLE 182 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY PACKAGING TYPE, 2023–2028 (USD MILLION)
・ TABLE 183 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2020–2022 (USD MILLION)
・ TABLE 184 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY DRUG DELIVERY, 2023–2028 (USD MILLION)
・ TABLE 185 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (USD MILLION)
・ TABLE 186 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (USD MILLION)
・ TABLE 187 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2020–2022 (KILOTON)
・ TABLE 188 MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY RAW MATERIAL, 2023–2028 (KILOTON)
10.6.2 GCC
10.6.2.1 UAE
10.6.2.1.1 INCREASING INITIATIVES FOR DOMESTIC PHARMACEUTICAL PRODUCTION TO DRIVE MARKET
・ TABLE 189 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 190 UAE: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.2 SAUDI ARABIA
10.6.2.2.1 MORE COMPREHENSIVE ACCESS TO HEALTHCARE SERVICES TO FUEL DEMAND FOR PHARMACEUTICALS
・ TABLE 191 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 192 SAUDI ARABIA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.2.3 REST OF GCC
10.6.3 SOUTH AFRICA
10.6.3.1 GRADUAL RISE IN USE OF GENERIC DRUGS TO DRIVE MARKET
・ TABLE 193 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 194 SOUTH AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
10.6.4 REST OF MIDDLE EAST & AFRICA
・ TABLE 195 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2020–2022 (USD MILLION)
・ TABLE 196 REST OF MIDDLE EAST & AFRICA: PHARMACEUTICAL PACKAGING MARKET, BY TYPE, 2023–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
・ FIGURE 41 OVERVIEW OF KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS BETWEEN 2019 AND 2023
11.3 REVENUE ANALYSIS
・ FIGURE 42 REVENUE ANALYSIS OF KEY COMPANIES (2020–2022)
11.4 MARKET SHARE ANALYSIS
11.4.1 RANKING ANALYSIS OF KEY MARKET PLAYERS, 2022
・ FIGURE 43 RANKING OF TOP 5 PLAYERS IN PHARMACEUTICAL PACKAGING MARKET, 2022
11.4.2 MARKET SHARE OF KEY PLAYERS, 2022
・ FIGURE 44 PHARMACEUTICAL PACKAGING MARKET SHARE, BY COMPANY (2022)
・ TABLE 197 PHARMACEUTICAL PACKAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX
11.5.1 STARS
11.5.2 EMERGING LEADERS 225
11.5.3 PERVASIVE PLAYERS 225
11.5.4 PARTICIPANTS
・ FIGURE 45 PHARMACEUTICAL PACKAGING MARKET: COMPANY EVALUATION MATRIX, 2022
11.5.5 COMPANY FOOTPRINT 227
・ TABLE 198 PACKAGING TYPE FOOTPRINT (25 COMPANIES)
・ TABLE 199 DRUG DELIVERY MODE FOOTPRINT (25 COMPANIES)
・ TABLE 200 REGION FOOTPRINT (25 COMPANIES)
・ TABLE 201 OVERALL COMPANY FOOTPRINT (25 COMPANIES)
11.6 START-UP/SME EVALUATION MATRIX
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES 231
11.6.4 STARTING BLOCKS 231
・ FIGURE 46 PHARMACEUTICAL PACKAGING MARKET: START-UP/SME EVALUATION MATRIX, 2022
11.6.5 COMPETITIVE BENCHMARKING
・ TABLE 202 PHARMACEUTICAL PACKAGING MARKET: LIST OF COMPANIES (25 COMPANIES)
11.7 COMPETITIVE SCENARIO AND TRENDS
11.7.1 PRODUCT LAUNCHES/DEVELOPMENTS
・ TABLE 203 PHARMACEUTICAL PACKAGING MARKET: PRODUCT LAUNCHES/ DEVELOPMENTS, 2019–2023
11.7.2 DEALS
・ TABLE 204 PHARMACEUTICAL PACKAGING MARKET: DEALS, 2019–2023
11.7.3 OTHER DEVELOPMENTS
・ TABLE 205 PHARMACEUTICAL PACKAGING MARKET: OTHER DEVELOPMENTS,
2019–2023
12 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, RIGHT TO WIN, STRATEGIC CHOICES, WEAKNESSES AND COMPETITIVE THREATS) *
12.1 KEY PLAYERS 246
12.1.1 BERRY GLOBAL INC. 246
・ TABLE 206 BERRY GLOBAL INC.: COMPANY OVERVIEW
・ FIGURE 47 BERRY GLOBAL INC.: COMPANY SNAPSHOT
・ TABLE 207 BERRY GLOBAL INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 208 BERRY GLOBAL INC.: PRODUCT LAUNCHES
・ TABLE 209 BERRY GLOBAL INC.: DEALS
・ TABLE 210 BERRY GLOBAL INC.: OTHER DEVELOPMENTS
12.1.2 GERRESHEIMER AG 251
・ TABLE 211 GERRESHEIMER AG: COMPANY OVERVIEW
・ FIGURE 48 GERRESHEIMER AG: COMPANY SNAPSHOT
・ TABLE 212 GERRESHEIMER AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 213 GERRESHEIMER AG: PRODUCT LAUNCHES
・ TABLE 214 GERRESHEIMER AG: DEALS
・ TABLE 215 GERRESHEIMER AG: OTHER DEVELOPMENTS
12.1.3 AMCOR PLC
・ TABLE 216 AMCOR PLC: COMPANY OVERVIEW 256
・ FIGURE 49 AMCOR PLC: COMPANY SNAPSHOT 257
・ TABLE 217 AMCOR PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 218 AMCOR PLC: PRODUCT LAUNCHES 259
・ TABLE 219 AMCOR PLC: DEALS
・ TABLE 220 AMCOR PLC: OTHER DEVELOPMENTS
12.1.4 SCHOTT AG
・ TABLE 221 SCHOTT AG: COMPANY OVERVIEW 261
・ FIGURE 50 SCHOTT AG: COMPANY SNAPSHOT 262
・ TABLE 222 SCHOTT AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 223 SCHOTT AG: PRODUCT LAUNCHES 263
・ TABLE 224 SCHOTT AG: DEALS
・ TABLE 225 SCHOTT AG: OTHER DEVELOPMENTS
12.1.5 APTARGROUP, INC. 266
・ TABLE 226 APTARGROUP, INC.: COMPANY OVERVIEW
・ FIGURE 51 APTARGROUP, INC.: COMPANY SNAPSHOT
・ TABLE 227 APTARGROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 228 APTARGROUP, INC.: PRODUCT LAUNCHES
・ TABLE 229 APTARGROUP, INC.: DEALS
・ TABLE 230 APTARGROUP, INC.: OTHER DEVELOPMENTS
12.1.6 BD
・ TABLE 231 BD: COMPANY OVERVIEW
・ FIGURE 52 BD: COMPANY SNAPSHOT
・ TABLE 232 BD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 233 BD: PRODUCT LAUNCHES
・ TABLE 234 BD: DEALS
・ TABLE 235 BD: OTHER DEVELOPMENTS
12.1.7 WESTROCK COMPANY 274
・ TABLE 236 WESTROCK COMPANY: COMPANY OVERVIEW
・ FIGURE 53 WESTROCK COMPANY: COMPANY SNAPSHOT
・ TABLE 237 WESTROCK COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 238 WESTROCK COMPANY: DEALS
・ TABLE 239 WESTROCK COMPANY: OTHER DEVELOPMENTS
12.1.8 NIPRO CORPORATION 276
・ TABLE 240 NIPRO CORPORATION: COMPANY OVERVIEW
・ FIGURE 54 NIPRO CORPORATION: COMPANY SNAPSHOT
・ TABLE 241 NIPRO CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 242 NIPRO CORPORATION: PRODUCT LAUNCHES
・ TABLE 243 NIPRO CORPORATION: DEALS
12.1.9 CATALENT, INC.
・ TABLE 244 CATALENT, INC.: COMPANY OVERVIEW
・ FIGURE 55 CATALENT, INC.: COMPANY SNAPSHOT
・ TABLE 245 CATALENT, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 246 CATALENT, INC.: DEALS
・ TABLE 247 CATALENT, INC.: OTHER DEVELOPMENTS
12.1.10 SEALED AIR
・ TABLE 248 SEALED AIR: COMPANY OVERVIEW 282
・ FIGURE 56 SEALED AIR: COMPANY SNAPSHOT 282
・ TABLE 249 SEALED AIR: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 250 SEALED AIR: PRODUCT LAUNCHES 283
・ TABLE 251 SEALED AIR: DEALS
12.1.11 WEST PHARMACEUTICAL SERVICES, INC.
・ TABLE 252 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
・ FIGURE 57 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
・ TABLE 253 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
・ TABLE 254 WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT LAUNCHES
・ TABLE 255 WEST PHARMACEUTICAL SERVICES, INC.: OTHER DEVELOPMENTS
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS/SOLUTIONS/SERVICES OFFERED, RECENT DEVELOPMENTS, MNM VIEW, RIGHT TO WIN, STRATEGIC CHOICES, WEAKNESSES AND COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.2 OTHER PLAYERS
12.2.1 ALPLA
・ TABLE 256 ALPLA: COMPANY OVERVIEW
12.2.2 ARDAGH GROUP S.A. 289
・ TABLE 257 ARDAGH GROUP S.A.: COMPANY OVERVIEW
12.2.3 CCL INDUSTRIES INC.
・ TABLE 258 CCL INDUSTRIES INC.: COMPANY OVERVIEW
12.2.4 FRANK NOE
・ TABLE 259 FRANK NOE: COMPANY OVERVIEW 291
12.2.5 GAPLAST GMBH
・ TABLE 260 GAPLAST GMBH: COMPANY OVERVIEW
12.2.6 LONZA
・ TABLE 261 LONZA: COMPANY OVERVIEW
12.2.7 MONDI GROUP
・ TABLE 262 MONDI GROUP: COMPANY OVERVIEW
12.2.8 NOLATO AB
・ TABLE 263 NOLATO AB: COMPANY OVERVIEW 295
12.2.9 ORIGIN PHARMA PACKAGING
・ TABLE 264 ORIGIN PHARMA PACKAGING: COMPANY OVERVIEW
12.2.10 COMAR
・ TABLE 265 COMAR: COMPANY OVERVIEW
12.2.11 BILCARE LIMITED
・ TABLE 266 BILCARE LIMITED: COMPANY OVERVIEW
12.2.12 SGD PHARMA
・ TABLE 267 SGD PHARMA: COMPANY OVERVIEW 299
12.2.13 SILGAN HOLDINGS INC.
・ TABLE 268 SILGAN HOLDINGS INC.: COMPANY OVERVIEW
12.2.14 VETTER PHARMA INTERNATIONAL GMBH
・ TABLE 269 VETTER PHARMA INTERNATIONAL GMBH: COMPANY OVERVIEW